REQUEST A DEMO
Total
USD $0.00
Search more companies

Acuramed Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Acuramed Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Acuramed Sdn. Bhd. is based in Malaysia. The head office is in Petaling Jaya. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on June 03, 2016. There was a net sales revenue increase of 266.72% reported in Acuramed Sdn. Bhd.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 264.79%. In 2022, Acuramed Sdn. Bhd.’s net profit margin increased by 3.24%.

Headquarters
C-3-3A, Block C, Pusat Komersil Parklane, Jalan Ss 7/26, Kelana Jaya
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Acuramed Sdn. Bhd. report to view the information.

Website: http://www.acura-med.com

Basic Information
Outstanding Shares:
Purchase the Acuramed Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Acuramed Sdn. Bhd. report to view the information.
Incorporation Date:
June 03, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Acuramed Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
266.72%
Total operating revenue
266.72%
Operating profit (EBIT)
372.6%
EBITDA
417.35%
Net Profit (Loss) for the Period
374.3%
Total assets
264.79%
Total equity
256.2%
Operating Profit Margin (ROS)
3.93%
Net Profit Margin
3.24%
Return on Equity (ROE)
21.18%
Quick Ratio
1.93%
Cash Ratio
1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?